BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

363 related articles for article (PubMed ID: 12078339)

  • 1. [Treatment of ovarian cancer].
    Cianti C
    Clin Ter; 2002; 153(2):135-44. PubMed ID: 12078339
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Treatment of epithelial ovarian cancer].
    Langmár Z; Csömör S
    Orv Hetil; 2006 Aug; 147(34):1627-32. PubMed ID: 17017677
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Medical treatment of epithelial ovarian cancer.
    González-Martín AJ
    Expert Rev Anticancer Ther; 2004 Dec; 4(6):1125-43. PubMed ID: 15606338
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Latest information in the diagnoses of ovarian carcinoma].
    Isonishi S
    Gan To Kagaku Ryoho; 2002 Aug; 29(8):1351-7. PubMed ID: 12214460
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnosis and management of epithelial ovarian cancer.
    Bhoola S; Hoskins WJ
    Obstet Gynecol; 2006 Jun; 107(6):1399-410. PubMed ID: 16738170
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Multidisciplinary treatment of recurrent epithelial ovarian carcinoma and prognostic analysis].
    Huang X; Cai SM; Tang J; Li ZT; Zang RY
    Zhonghua Fu Chan Ke Za Zhi; 2004 Sep; 39(9):602-5. PubMed ID: 15498187
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Second line platinum-based intraperitoneal chemotherapy for advanced ovarian cancer.
    Milczek T; Klasa-Mazurkiewicz D; Emerich J; Kobierski J
    Acta Obstet Gynecol Scand; 2009; 88(4):463-7. PubMed ID: 19235559
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Impact of dose delivery of postoperative first-line chemotherapy on prognosis of stage III C epithelial ovarian carcinoma].
    Zhao XD; Zhang Q; Zhang Y
    Ai Zheng; 2005 Aug; 24(8):1002-5. PubMed ID: 16086882
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Advances in the management of epithelial ovarian cancer.
    Berkenblit A; Cannistra SA
    J Reprod Med; 2005 Jun; 50(6):426-38. PubMed ID: 16050567
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Epithelial cancer of the ovary: current data].
    Ozols RF
    Bull Cancer; 1993 Nov; 80(11):955-70. PubMed ID: 7915918
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recent advances in the management of women with ovarian cancer.
    Eltabbakh GH
    Minerva Ginecol; 2004 Feb; 56(1):81-9. PubMed ID: 14973412
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ovarian carcinosarcomas: clinicopathological prognostic factors and evaluation of chemotherapy regimens containing platinum.
    Cicin I; Saip P; Eralp Y; Selam M; Topuz S; Ozluk Y; Aydin Y; Topuz E
    Gynecol Oncol; 2008 Jan; 108(1):136-40. PubMed ID: 17936342
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Ovarian carcinoma: current therapeutic aspects. A review].
    Buser K; Hänggi W; Greiner R; Schatzmann E
    Schweiz Med Wochenschr; 1990 Nov; 120(44):1617-32. PubMed ID: 2251477
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activity of chemotherapy in mucinous epithelial ovarian cancer: a retrospective study.
    Pisano C; Greggi S; Tambaro R; Losito S; Iodice F; Di Maio M; Ferrari E; Falanga M; Formato R; Iaffaioli VR; Pignata S
    Anticancer Res; 2005; 25(5):3501-5. PubMed ID: 16101169
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Systemic therapy in recurrent ovarian cancer: current treatment options and new drugs.
    Harter P; Hilpert F; Mahner S; Heitz F; Pfisterer J; du Bois A
    Expert Rev Anticancer Ther; 2010 Jan; 10(1):81-8. PubMed ID: 20014888
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Update on the management of ovarian cancer.
    Ozols RF
    Cancer J; 2002; 8 Suppl 1():S22-30. PubMed ID: 12075699
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of prognostic factors after positive second-look surgery in epithelial ovarian carcinoma.
    McCreath WA; Eisenhauer EL; Abu-Rustum NR; Venkatraman ES; Caceres A; Bier R; Huh J; Cho J; Barakat RR; Chi DS
    Gynecol Oncol; 2006 Jul; 102(1):8-14. PubMed ID: 16427689
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ovarian cancer.
    Colombo N; Van Gorp T; Parma G; Amant F; Gatta G; Sessa C; Vergote I
    Crit Rev Oncol Hematol; 2006 Nov; 60(2):159-79. PubMed ID: 17018256
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Extreme drug resistance assay results do not influence survival in women with epithelial ovarian cancer.
    Karam AK; Chiang JW; Fung E; Nossov V; Karlan BY
    Gynecol Oncol; 2009 Aug; 114(2):246-52. PubMed ID: 19500821
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clinical efficacy analysis of chemotherapy to lymph node metastasis in epithelial ovarian cancer].
    Wu LY; Zhang R; Huang MN; Li N; Wang GX; Liu LY
    Ai Zheng; 2003 Apr; 22(4):424-7. PubMed ID: 12704005
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.